1-4 of 4
David B. Agus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Trial of Orteronel (TAK-700)—an Investigational 17,20-Lyase Inhibitor—in Patients with Metastatic Castration-Resistant Prostate Cancer

Robert Dreicer, David MacLean, Ajit Suri, Walter M. Stadler, Daniel Shevrin, Lowell Hart, Gary R. MacVicar, Omid Hamid, John Hainsworth, Mitchell E. Gross, Yuanjun Shi, Iain J. Webb, David B. Agus
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (5): 1335–1344.
https://doi.org/10.1158/1078-0432.CCR-13-2436
Published: 02 March 2014
View article titled, Phase I/II Trial of Orteronel (TAK-700)—an Investigational 17,20-Lyase Inhibitor—in Patients with Metastatic Castration-Resistant Prostate Cancer
Open the PDF for Phase I/II Trial of Orteronel (TAK-700)—an Investigational 17,20-Lyase Inhibitor—in Patients with Metastatic Castration-Resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Antibody to Vascular Endothelial Growth Factor Slows Growth of an Androgen-independent Xenograft Model of Prostate Cancer

William D. Fox, Brian Higgins, Krista M. Maiese, Marija Drobnjak, Carlos Cordon-Cardo, Howard I. Scher, David B. Agus
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (10): 3226–3231.
Published: 01 October 2002
View article titled, Antibody to Vascular Endothelial Growth Factor Slows Growth of an Androgen-independent Xenograft Model of Prostate Cancer
Open the PDF for Antibody to Vascular Endothelial Growth Factor Slows Growth of an Androgen-independent Xenograft Model of Prostate Cancer in another window
Journal Articles

17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/ neu and Inhibits the Growth of Prostate Cancer Xenografts

David B. Solit, Fuzhong F. Zheng, Maria Drobnjak, Pamela N. Münster, Brian Higgins, David Verbel, Glenn Heller, William Tong, Carlos Cordon-Cardo, David B. Agus, Howard I. Scher, Neal Rosen
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (5): 986–993.
Published: 01 May 2002
View article titled, 17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/ <em>neu</em> and Inhibits the Growth of Prostate Cancer Xenografts
Open the PDF for 17-Allylamino-17-demethoxygeldanamycin Induces the Degradation of Androgen Receptor and HER-2/ <em>neu</em> and Inhibits the Growth of Prostate Cancer Xenografts in another window
Journal Articles

Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase

Lisa M. Butler, Yael Webb, David B. Agus, Brian Higgins, Thomas R. Tolentino, Martha C. Kutko, Michael P. LaQuaglia, Marija Drobnjak, Carlos Cordon-Cardo, Howard I. Scher, Ronald Breslow, Victoria M. Richon, Richard A. Rifkind, Paul A. Marks
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (4): 962–970.
Published: 01 April 2001
View article titled, Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase
Open the PDF for Inhibition of Transformed Cell Growth and Induction of Cellular Differentiation by Pyroxamide, an Inhibitor of Histone Deacetylase in another window